Anil K. Sood, MD, elected to the National Academy of Medicine
Congratulations to SGO member Anil K. Sood, MD, professor of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX, who has been elected to the National Academy of Medicine (NAM) for his discovery of the mechanistic basis for effects of chronic stress on cancer and the identification of the mechanisms behind paraneoplastic thrombocytosis. His research is focused on improving the understanding of the mechanisms underlying ovarian cancer growth and progression, developing new biologically targeted therapies and the role of non-coding RNAs as biomarkers and for therapeutic applications.
Over the course of his 23-year career as a physician-scientist, Dr. Sood has worked on developing new therapies aimed at the tumor microenvironment and understanding the mechanisms of RNA interference. Since joining MD Anderson in 2002, Dr. Sood has held various leadership positions, including co-director of the Center for RNA Interference and Non-Coding RNAs, director of the Blanton-Davis Ovarian Cancer Research Program and co-leader of the Ovarian Cancer Moon Shot®.
Dr. Sood has received various awards and recognition for his research, including the Hunter Award, the Margaret Greenfield/Carmel Cohen Excellence in Ovarian Cancer Research Prize and the GCF/Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher. He is also an elected member of the American Society for Clinical Investigation (ASCI), the American Association for the Advancement of Science (AAAS) and the Association of American Physicians (AAP), and was selected as an American Cancer Society Research Professor in 2017. Additionally, Dr. Sood has served as Chair of the Research Grants and Awards Committee for the Foundation for Women’s Cancer.